Medpace demonstrates strong financial performance and growth in the CRO market, despite facing challenges in the short term. Read why MEDP stock is a Strong Buy.

(RTTNews) - Thermo Fisher Scientific (TMO) Tuesday announced that it has entered a 10-year virtual power purchasing agreement with international renewable energy developer X-ELIO. This collaboration ...

Thermo Fisher (TMO) announced a 10-year virtual power purchasing agreement with international renewable energy developer X-ELIO designed to ...

Earlier this week, Franco-German peer Sartorius reported preliminary annual results that beat expectations and posted a 23.1% ...

Despite recent evidence of its financial turnaround, Thermo Fisher’s layoff spree will continue into 2025. | Despite recent ...

Shares of Thermo Fisher Scientific Inc. TMO slipped 2.22% to $580.57 Tuesday, on what proved to be an all-around great ...

Thermo Fisher Scientific Inc. (NYSE:TMO), a leading player in the Life Science Tools & Diagnostics sector, has been navigating a complex market landscape characterized by both challenges and ...

Shares of Thermo Fisher Scientific Inc. TMO slid 1.48% to $597.75 Friday, on what proved to be an all-around dismal trading ...

Shares of Thermo Fisher Scientific jumped Thursday after the company's fourth-quarter results topped estimates, as sales increased across all four of its divisions.

We recently published a list of the 10 Best Cancer Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Thermo Fisher Scientific Inc.

The cuts at two Massachusetts plants follow further site closures and layoffs across the company over the past few years.

ELIO, Thermo Fisher Scientific is closer to its goal of powering its European sites with 100% renewable energy ...